CERN:NSD-Cerner Corporation (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 78.80

Change

0.00 (0.00)%

Market Cap

USD 23.86B

Volume

4.18M

Average Target Price

USD 83.63 (+6.12%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental and care coordination solutions. Further, it provides tech-enabled services, such as implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third-party administrator services; and complementary hardware and devices for third parties. The company serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-06-20 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
TXG 10x Genomics, Inc

N/A

USD21.35B N/A N/A
GDRX GoodRx Holdings, Inc

N/A

USD14.79B 927.27 238.21
CHNG Change Healthcare Inc

N/A

USD7.18B N/A 17.34
HQY HealthEquity, Inc

N/A

USD6.45B 1,357.37 47.09
OMCL Omnicell, Inc

N/A

USD6.21B 182.80 52.21
RCM R1 RCM Inc

N/A

USD5.99B 72.63 31.61
PGNY Progyny, Inc

N/A

USD5.80B 792.68 295.04
INOV Inovalon Holdings, Inc

N/A

USD5.00B 147.88 29.08
PINC Premier, Inc

N/A

USD4.19B 16.73 12.17
ACCD Accolade, Inc

N/A

USD3.48B -99,999.99 N/A

ETFs Containing CERN

Symbol Name Weight Mer Price(Change) Market Cap
PSJ Invesco Dynamic Software .. 0.00 % 0.56 %

N/A

USD0.62B
TPLC Timothy Plan US Large/Mid.. 0.00 % 0.52 %

N/A

USD0.19B
USLV:LSE SSgA SPDR ETFs Europe I P.. 0.00 % 0.35 %

N/A

USD0.18B
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.65 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.41% 36% F 35% F
Dividend Return 0.28% 50% F 14% F
Total Return 0.69% 36% F 35% F
Trailing 12 Months  
Capital Gain 7.68% 35% F 27% F
Dividend Return 0.85% 75% C 14% F
Total Return 8.53% 35% F 26% F
Trailing 5 Years  
Capital Gain 43.77% 40% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.77% 40% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 7.51% 31% F 49% F
Dividend Return 0.45% 33% F 11% F
Total Return 7.96% 27% F 47% F
Risk Return Profile  
Volatility (Standard Deviation) 15.93% 85% B 84% B
Risk Adjusted Return 49.96% 42% F 69% D+
Market Capitalization 23.86B 100% A+ 95% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.17 82% B- 33% F
Price/Book Ratio 5.51 52% F 28% F
Price / Cash Flow Ratio 16.60 38% F 27% F
EV/EBITDA 13.69 95% A 58% F
Management Effectiveness  
Return on Equity 19.70% 89% B+ 87% B+
Return on Invested Capital 8.63% 90% A- 75% C
Return on Assets 7.26% 93% A 89% B+
Debt to Equity Ratio 29.81% 53% F 52% F
Technical Ratios  
Short Ratio 4.67 62% D- 35% F
Short Percent 4.76% 62% D- 40% F
Beta 0.73 70% C- 76% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector